Program Structure

Built around a personalized planner

Attendees could work through a personalized event planner to map sessions, hubs, and networking moments across the three-day schedule, aligning their time with manufacturing, supply chain, market access, and investment tracks.

The final agenda was made accessible online ahead of the event, giving delegates visibility into session timing, optional add-ons, and collaboration opportunities before arriving in Miami.

Cell and gene therapy has shifted from a specialized research area into a defining force across modern medicine, reshaping how clinicians approach inherited disorders, cancer, and degenerative conditions. As investment flows into manufacturing capacity and clinical infrastructure, the field is increasingly defined by collaboration between academic pioneers, biotech innovators, and pharmaceutical leaders working toward scalable, patient-ready treatments. Events that gather these communities help translate laboratory progress into accessible therapies, creating shared language around regulation, reimbursement, and long-term supply strategy.

A well-designed conference program reflects the maturity of the sector itself, balancing deep scientific sessions with practical tracks on manufacturing, supply chain, market access, and investment. Attendees benefit from personalized planners that allow them to navigate parallel hubs, choosing between immuno-oncology breakthroughs, stem cell advances, and translational discussions on commercialization. Co-locating a cell and gene therapy meeting with broader stem cell and regenerative medicine gatherings amplifies cross-disciplinary insight and helps align timelines across development pipelines.

Beyond formal sessions, the value of a major industry gathering often lies in the conversations that happen between presentations, during shared meals, and at evening receptions. Senior executives from biotech, pharma, and venture groups use these moments to forge partnerships, scout emerging technologies, and pressure-test clinical and commercial assumptions. A neutral, well-organized venue with comfortable accommodation and intuitive logistics allows participants to focus on the work of advancing therapies, strengthening the connective tissue that turns isolated discoveries into collective progress.